You searched for "cancer"
Prostate Cancer UK: Faster Diagnosis Standard: Short course (20 weeks long) Deadline 5 Jan 2025 (Free)
You will learn some best practice models and drive change in your Trust, constructing a model with industry experts to deliver a new pathway that works for your patients. Unlock the potential to implement Faster Diagnosis Standards and accelerate diagnosis for men affected by prostate cancer with our free 20-week leadership programme. Guided by expert programme managers, you'll shape and implement your own project and gain crucial leadership and change management skills. We’ll support you from the initial planning stages of your project through to implementation and review.The Royal Marsden: Cancer of the Vulva National Symposium and Stakeholder Meeting in Partnership With Lady Garden Foundation
The first national meeting in collaboration with Lady Garden Foundation to address the unique challenges in the diagnosis, treatment and management of cancer of the vulva.The Royal Marsden: An Introduction to the Science Behind Systemic Treatments for Prostate, Bladder, and Kidney Cancer
Dr Elaine Vickers will provide an introduction to the science behind a wide variety of targeted therapies and immunotherapies given to people with prostate, bladder and kidney cancer.The Royal Marsden: Gynaecological Cancers 2-Day Conference
Programme to reflect the breadth of professional expertise required to care for women with gynaecological cancers, and their diverse needs with an emphasis on practical skills. This study day is aimed at medical, nursing and allied health care professionals who are involved in the care of individuals with gynaecological cancer.
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy
Neutrophil-to-lymphocyte ratio has been shown to be a prognostic factor in a number of different cancers. This is one of the largest studies to date to evaluate its effect on overall survival in patients who have undergone radical prostatectomy (RP)...
Dilemma of second primary tumour
Long-term survival in localised prostate cancer (CaP) can be achieved with treatment by either radical prostatectomy (RP) or external beam radiotherapy (EBRT). The development of second primary tumour is poorly understood in such cases. This retrospective study included 84,397 cases...New senior appointments at The Urology Foundation
New Chief Executive appointed The Urology Foundation (TUF) has appointed Rebecca Porta as Chief Executive. An established and experienced charity Chief Executive, Rebecca brings a wealth of experience having held senior roles within some of the UK’s leading health and...The urologist’s tale
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). The Canterbury Tales, written by Geoffrey Chaucer (c.1340’s-1400) in the 14th Century, is...New senior appointments at The Urology Foundation
The Urology Foundation (TUF) has appointed Rebecca Porta as Chief Executive. An established and experienced charity Chief Executive, Rebecca brings a wealth of experience having held senior roles within some of the UK’s leading health and medical research charities.
